Can Lisinopril and Metoprolol Be Given Together?
Yes, lisinopril (ACE inhibitor) and metoprolol (beta-blocker) can and should be given together when clinically indicated—this is a well-established, guideline-supported combination for multiple cardiovascular conditions.
Guideline Support for Combination Therapy
The 2024 ESC Guidelines explicitly recommend beta-blockers be combined with other major blood pressure-lowering drug classes (including ACE inhibitors) when there are compelling indications such as angina, post-myocardial infarction, heart failure with reduced ejection fraction, or heart rate control 1. This represents a Class I, Level A recommendation—the highest level of evidence 1.
For hypertension management specifically, the preferred initial combinations are a RAS blocker (ACE inhibitor or ARB) with either a calcium channel blocker or diuretic 1. However, beta-blockers are appropriately added when additional indications exist beyond blood pressure control alone 1.
Clinical Evidence Supporting the Combination
Blood Pressure Control
- Multiple studies demonstrate that combining lisinopril with beta-blockers produces additive blood pressure reduction 2, 3
- In patients inadequately controlled on atenolol alone, adding lisinopril 10-20 mg produced additional reductions of 7.1/5.4 mmHg lying and 7.6/4.7 mmHg standing blood pressure 3
- The combination is as effective as traditional beta-blocker plus diuretic therapy 2
Complementary Mechanisms
The combination provides complementary cardiovascular protection by targeting two interlinked pathways: the sympathetic nervous system (beta-blockers) and the renin-angiotensin-aldosterone system (ACE inhibitors) 4. This dual mechanism addresses multiple aspects of cardiovascular risk across the disease continuum 4.
Safety Considerations and Monitoring
Primary Concern: Hypotension
The main risk when combining these agents is excessive blood pressure reduction 5. To minimize this risk:
- Monitor blood pressure closely after initiating combination therapy 5
- Consider reducing or temporarily discontinuing diuretics before starting lisinopril if the patient is already on beta-blocker therapy 5
- If diuretic discontinuation isn't possible, reduce the starting dose of lisinopril 5
- Watch for symptomatic orthostatic hypotension, particularly in volume or salt-depleted patients 5
Additional Monitoring Parameters
- Serum potassium: ACE inhibitors can increase potassium levels (mean increase ~0.1 mEq/L), though this is generally modest 5
- Renal function: Monitor periodically, especially if NSAIDs are co-administered 5
- Heart rate: Beta-blockers will reduce heart rate; ensure it doesn't become excessively bradycardic 2
Important Drug Interaction Note
A recent case report documented profound hypotension when tizanidine (a muscle relaxant) was given with lisinopril and metoprolol 6. While this involved a third agent, it underscores the importance of reviewing all medications that can affect blood pressure when using this combination 6.
Contraindications to Lisinopril (Regardless of Beta-Blocker Use)
Do not use lisinopril in patients with 5:
- History of angioedema or hypersensitivity to ACE inhibitors
- Hereditary or idiopathic angioedema
- Concurrent use with aliskiren in diabetic patients
Clinical Scenarios Where This Combination Is Particularly Appropriate
- Post-myocardial infarction: Both agents have mortality benefits 1, 4
- Heart failure with reduced ejection fraction: Both are cornerstone therapies 7, 4
- Hypertension with angina: Beta-blockers treat angina while ACE inhibitors provide additional blood pressure control 1, 4
- Hypertension requiring multiple agents: When blood pressure isn't controlled on monotherapy 1, 3
Practical Prescribing Approach
When combining these medications:
- Start with standard doses unless the patient has risk factors for hypotension (elderly, volume depleted, frail) 1
- Measure blood pressure 1 hour and 6 hours after the first combined dose if feasible, as lisinopril shows onset at 1 hour with peak effect at 6 hours 5
- Recheck blood pressure at 24 hours to assess trough effect 5
- Titrate to target doses over approximately 3 months to optimize cardiovascular protection while maintaining patient confidence and adherence 1
- Consider fixed-dose combination pills when available to improve adherence 1